Giving boosters to vaccinated people in rich countries, while millions in poor countries go unvaccinated, is nothing short of greed, 前記 World Health Organization director-general Tedros Adhanom Ghebreyesus on Monday. WHO wants vaccine equity.
That viewpoint could pose a problem for the 147 million Americans 予防接種を受けた with Pfizer and Moderna shots who are wondering whether they need a booster. Rolling out boosters in the U.S. will consume millions of doses and threaten Team Biden’s magnanimous plan to lead the world in vaccinating poor countries.
アンソニー・ファウチ, top health adviser to President Biden, waffled on Sunday, saying federal officials “don’t feel that we need to tell people right now you need to be boosted,” but adding the answer may change.
That’s not helpful. The public wants answers, not a repeat of the run-around they got over whether to wear a mask.
When Pfizer publicly announced last Thursday that it would apply soon to the FDA for emergency authorization to offer boosters, the FDA and CDC shut down the discussion with a terse, one-sentence statement that boosters are not needed. Even before seeing Pfizer’s data. No data and no scientific discussion.
月曜日に, Tedros condemned vaccine disparities between rich and poor nations and called on Pfizer and Moderna to vaccinate the poor countries instead of supplying boosters to the wealthy ones.
That’s the issue. In June, Team Biden pledged 500 million doses of future vaccine supply to the World Health Organization’s project COVAX. Those doses will be paid for by American taxpayers. But now public health authorities and the International Monetary Fund are warning that boosters will consume manufacturing capacity and retard sending shots to unvaccinated poor countries. The IMF said it’s a problem of vaccine privilege.
その間, health officials in some nations are moving ahead with boosters to protect their own populations.
Israel announced on Sunday that it is starting to offer third shots to people over 70 and fragile patients. Infections in Israel are surging, and more than half the patients hospitalized with serious cases are vaccinated.
The United Kingdom is rolling out a booster program in September. France is already recommending boosters to cancer patients and others with immune deficiencies.
But in the U.S., the resistance appears to be largely political, not medical. ”It’s impossible to ignore the global situation,” Emory University biostatistician Natalie Dean told the New York Times. “It’s hard for me to imagine getting a third dose,” when many people in other countries are unvaccinated. 博士. Celine Gounder of Bellevue Hospital in New York said the U.S. should “not hoard more doses to give third doses” ここに.